Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/3/13 → 5/3/19 |
Funding
- Merck Sharp & Dohme Corporation (Prot #006-00)
Prot #006-00: A Multicenter, Randomized, Controlled, Two-Arm, Phase III Study to Evaluate the Safety and Efficacy of MK-3475 Compared to Ipilimumab in Patients with Advanced Melanoma
- Chandra, Sunandana (PD/PI)
Project: Research project